The Clinical and Medical Affairs (CMA) global function at Teleflex is responsible for our clinical, medical, and scientific operations globally. Through research, education, and communication, the CMA team supports the safe and effective use of our products, demonstrating our commitment to patients and the delivery of exceptional healthcare. This commitment continues with our Patient Access and Reimbursement team, which advocates for coverage and access to products. The goals of patient and product safety, as well as the community and charitable programs, demonstrate Teleflex's mission to innovate for better patient outcomes and give back to the communities in which we live and work around the world.
"Our dedicated team of professionals executes on key initiatives that support healthcare providers around the world who deliver essential care. We believe all patients deserve access to innovative technology."
Michelle Fox, RN, BSN
Corporate Vice President and
Chief Medical Officer
Teleflex provides comprehensive product training and education. We use hands-on skills labs, procedural training, our Teleflex Academy online learning, speaker series, and conferences to provide a holistic educational approach. Between both our in-person and virtual platforms, we educated more than 180,000 healthcare professionals on the safe and effective use of our products in 2022.
Obtaining robust clinical evidence supporting our products is paramount at Teleflex. Our Global Clinical Operations team is central to the coordination of clinical research activities across the organization. These clinical trials and other research conducted at Teleflex can help shape the standard of patient care.
Our Scientific Communications Team uses clinical evidence to highlight clinical and patient outcomes that reinforce the value proposition of products across the organization. The team facilitates the publication of peer-reviewed literature and conference abstracts and collaborates with Health Care Providers around the world who present clinical research at scientific meetings. The communication of clinical evidence improves market access, facilitates product adoption, and supports reimbursement, ultimately helping to shape the standard of care.
Our global Scientific Affairs team leads our clinical strategy for meeting the Medical Device Regulation in Europe and conducts clinical evaluations, post-market clinical follow-up for our Class III, II and I devices per EU MDR 2017/745.
Teleflex is an advocate for patient, physician, and facility access to our medical devices and procedures. For example, we analyze real-world data on the UroLift® System in order to better understand diverse patient populations, to identify potential health disparities, and to promote patient access and health equity. The Patient Access and Reimbursement team also advocates for greater access to investigational devices through improving our clinical trial diversity, which can help expand our product coverage among these populations. In addition, Teleflex engages in direct advocacy as well as being an active participant in coalitions and trade associations.
Teleflex is committed to developing impactful medical devices for patients, healthcare providers, and caregivers who use our products. The CMA team's extensive research, education resources, and publications on our products help support both the safe and effective use of our devices by physicians and positive outcomes for patients.
The CMA team provides expert clinical advice to the product development teams on enhancing device safety and to healthcare professionals on the safe and effective use of our products.
Teleflex's JOIN program, our employee-driven community engagement and volunteerism initiative, continues to be a call to join in and act with purpose. With JOIN, our employees support local charities and causes and foster a greater sense of meaning and purpose in their everyday jobs and beyond.Learn More
Teleflex believes that we have a responsibility to provide support to the public when needed. Our Humanitarian Product Donation Program aids in the event of natural disasters and helps improve the quality of life of those living in vulnerable situations. Additionally, the Teleflex Foundation donates to charities and non-profits which help improve the health and quality of people's lives.
Teleflex is committed to supporting educational endeavors, the advancement of scientific knowledge, improved patient outcomes and the quality of healthcare, through our grant programs.
Do you have an idea for a product or service to share with Teleflex? We'd love to hear about it.
Corporate Vice President and Chief Medical Officer
Michelle Fox, RN BSN, was named Corporate Vice President & Chief Medical Officer for Teleflex in February 2020. Michelle and her leadership team set the clinical vision and strategy for the organization. She has lectured nationally and internationally on the impact of strong collaboration between Clinical and Medical Affairs teams and professional medical/nursing societies and organizations. She offers a rare blend of strong clinical practice and leadership, driven by her desire to improve patient outcomes, and tempered by a clear understanding of the challenges facing healthcare today.
Vice President of Clinical and Medical Affairs, Vascular and Interventional
Medical Director of Interventional Cardiology
Global Medical Safety Director
Vice President of Clinical and Medical Affairs
Vice President, Reimbursement & Healthcare Policy
Vice President of Global Clinical and Scientific Operations, Medical Director of Interventional Urology
Head of CMA, Asia Pacific